Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
Article has an altmetric score of 6

See more details

Posted by 9 X users
Referenced by 2 Bluesky users
  • Article usage
  • Citations to this article (0)

Advertisement

ResearchIn-Press PreviewAutoimmunityImmunology Open Access | 10.1172/JCI187862

OCA-B promotes pathogenic maturation of stem-like CD4+ T cells and autoimmune demyelination

Erik P. Hughes,1 Amber R. Syage,1 Elnaz Mirzaei Mehrabad,2 Thomas E. Lane,3 Benjamin T. Spike,2 and Dean Tantin1

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Hughes, E. in: JCI | PubMed | Google Scholar

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Syage, A. in: JCI | PubMed | Google Scholar

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Mirzaei Mehrabad, E. in: JCI | PubMed | Google Scholar

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Lane, T. in: JCI | PubMed | Google Scholar

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Spike, B. in: JCI | PubMed | Google Scholar

1Department of Pathology, University of Utah School of Medicine, Salt Lake City, United States of America

2Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, United States of America

3Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, United States of America

Find articles by Tantin, D. in: JCI | PubMed | Google Scholar |

Published April 29, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI187862.
Copyright © 2025, Hughes et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 29, 2025 - Version history
View PDF
Abstract

Stem-like T cells selectively contribute to autoimmunity, but the activities that promote their pathogenicity are incompletely understood. Here, we identify the transcription coregulator OCA-B as a driver of the pathogenic maturation of stem-like CD4+ T cell to promote autoimmune demyelination. Using two human multiple sclerosis (MS) datasets, we show that POU2AF1, the gene encoding OCA-B, is elevated in CD4+ T cells from MS patients. We show that T cell-intrinsic OCA-B loss protects mice from experimental autoimmune encephalomyelitis (EAE) while preserving responses to viral CNS infection. In EAE models driven by antigen reencounter, OCA-B deletion nearly eliminates CNS infiltration, proinflammatory cytokine production and clinical disease. OCA-B-expressing CD4+ T cells of mice primed with autoantigen express an encephalitogenic gene program and preferentially confer disease. In a relapsing-remitting EAE model, OCA-B loss protects mice specifically at relapse. During remission, OCA-B promotes the expression of Tcf7, Slamf6, and Sell in proliferating CNS T cell populations. At relapse timepoints, OCA-B loss results in both the accumulation of an immunomodulatory CD4+ T cell population expressing Ccr9 and Bach2, and loss of pro-inflammatory gene expression from Th17 cells. These results identify OCA-B as a driver of pathogenic CD4+ T cells.

Graphical Abstract
graphical abstract
Supplemental material

View

View Supplemental Table 1

View Supplemental Table 2

View Supplemental Table 3

View Supplemental Table 4

View Supplemental Table 5

Version history
  • Version 1 (April 29, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 6
  • Article usage
  • Citations to this article (0)

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 9 X users
Referenced by 2 Bluesky users
See more details